首页> 外文期刊>BMC Cancer >N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer
【24h】

N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer

机译:N-cadherin在癌症转移中,其在血液恶性肿瘤中的出现作用和作为癌症治疗靶标的潜力

获取原文
           

摘要

In many types of solid tumours, the aberrant expression of the cell adhesion molecule N-cadherin is a hallmark of epithelial-to-mesenchymal transition, resulting in the acquisition of an aggressive tumour phenotype. This transition endows tumour cells with the capacity to escape from the confines of the primary tumour and metastasise to secondary sites. In this review, we will discuss how N-cadherin actively promotes the metastatic behaviour of tumour cells, including its involvement in critical signalling pathways which mediate these events. In addition, we will explore the emerging role of N-cadherin in haematological malignancies, including bone marrow homing and microenvironmental protection to anti-cancer agents. Finally, we will discuss the evidence that N-cadherin may be a viable therapeutic target to inhibit cancer metastasis and increase tumour cell sensitivity to existing anti-cancer therapies.
机译:在许多类型的实体瘤中,细胞粘附分子N-Cadherin的异常表达是上皮 - 间充质转换的标志,导致采集侵袭性肿瘤表型。这种过渡赋予肿瘤细胞具有逃离原发性肿瘤的限制和转移到二级地点的能力。在这篇综述中,我们将讨论N-Cadherin如何积极促进肿瘤细胞的转移行为,包括其参与介导这些事件的关键信号传导途径。此外,我们将探讨N-Cadherin在血液恶性肿瘤中的新兴作用,包括骨髓归巢和对抗癌剂的微环境保护。最后,我们将讨论N-Cadherin可以是抑制癌症转移的可行治疗靶标的证据,并提高肿瘤细胞对现有抗癌疗法的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号